Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1949 1
1950 3
1951 5
1952 1
1953 6
1954 2
1955 6
1956 2
1957 4
1958 3
1959 5
1960 4
1961 1
1962 9
1963 40
1964 44
1965 21
1966 22
1967 21
1968 35
1969 36
1970 30
1971 45
1972 48
1973 44
1974 47
1975 56
1976 41
1977 59
1978 55
1979 62
1980 70
1981 75
1982 73
1983 80
1984 79
1985 91
1986 90
1987 60
1988 63
1989 105
1990 75
1991 120
1992 99
1993 94
1994 132
1995 111
1996 130
1997 134
1998 129
1999 129
2000 138
2001 138
2002 159
2003 174
2004 145
2005 186
2006 196
2007 195
2008 196
2009 215
2010 209
2011 205
2012 261
2013 239
2014 235
2015 292
2016 282
2017 286
2018 291
2019 292
2020 334
2021 386
2022 326
2023 312
2024 290
2025 346
2026 132

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,411 results

Results by year

Filters applied: . Clear all
Page 1
Lupus Vasculitis.
Calle-Botero E, Abril A. Calle-Botero E, et al. Curr Rheumatol Rep. 2020 Aug 26;22(10):71. doi: 10.1007/s11926-020-00937-0. Curr Rheumatol Rep. 2020. PMID: 32845454 Review.
PURPOSE OF REVIEW: The purpose of this manuscript is to review the most recent literature pertinent to the presence of vasculitis in patients with systemic lupus erythematosus (SLE), including previously published landmark articles and studies and to u …
PURPOSE OF REVIEW: The purpose of this manuscript is to review the most recent literature pertinent to the presence of vasculitis in …
Drug-induced vasculitis: a clinical and pathological review.
Radić M, Martinović Kaliterna D, Radić J. Radić M, et al. Neth J Med. 2012 Jan;70(1):12-7. Neth J Med. 2012. PMID: 22271809 Free article. Review.
Drug-induced vasculitis is an inflammation of blood vessels caused by the use of various pharmaceutical agents. ...Increasing understanding of the pathophysiological characteristics of all inflammatory vasculitides should lead to better diagnostic and therapeutic ap …
Drug-induced vasculitis is an inflammation of blood vessels caused by the use of various pharmaceutical agents. ...Increasing underst …
Neuropsychiatric involvement in systemic lupus erythematosus: A review.
Carrión-Barberà I, Salman-Monte TC, Vílchez-Oya F, Monfort J. Carrión-Barberà I, et al. Autoimmun Rev. 2021 Apr;20(4):102780. doi: 10.1016/j.autrev.2021.102780. Epub 2021 Feb 18. Autoimmun Rev. 2021. PMID: 33609799 Review.
The neuropsychiatric involvement in systemic lupus erythematosus (NPSLE) is a challenge for clinicians, both at a diagnostic and therapeutic level. ...In recent years, some authors have tried excluding minor neuropsychiatric manifestations in order to try to …
The neuropsychiatric involvement in systemic lupus erythematosus (NPSLE) is a challenge for clinicians, both at a diagn …
Vasculitis in systemic lupus erythematosis.
Calamia KT, Balabanova M. Calamia KT, et al. Clin Dermatol. 2004 Mar-Apr;22(2):148-56. doi: 10.1016/j.clindermatol.2003.12.022. Clin Dermatol. 2004. PMID: 15234016 Review.
Vasculitis in connective tissue diseases is not an uncommon complication. Vasculitis complicates both rheumatoid arthritis and systemic lupus erythematosis (SLE) in about 4% of cases. ...Connective tissue disease-associated vasculitis is separat …
Vasculitis in connective tissue diseases is not an uncommon complication. Vasculitis complicates both rheumatoid arthritis and …
Vasculitis in systemic lupus erythematosus.
Drenkard C, Villa AR, Reyes E, Abello M, Alarcón-Segovia D. Drenkard C, et al. Lupus. 1997;6(3):235-42. doi: 10.1177/096120339700600304. Lupus. 1997. PMID: 9104729 Review.
A single episode of vasculitis occurred in 119 and two or more in 75 patients. Vasculitis was cutaneous in 160, visceral in 24, both in 10. ...Lupus manifestations associated with vasculitis in univariate logistic regression included myocarditis, psych …
A single episode of vasculitis occurred in 119 and two or more in 75 patients. Vasculitis was cutaneous in 160, visceral in 24 …
Vasculitis in systemic lupus erythematosus.
D'Cruz D. D'Cruz D. Lupus. 1998;7(4):270-4. doi: 10.1191/096120398678920082. Lupus. 1998. PMID: 9643317 Review.
Vasculitis frequently complicates SLE, is associated with significant morbidity and mortality, and its pathophysiology is poorly understood. In seriously ill lupus patients with vasculitis, immunosuppression should almost always be considered....
Vasculitis frequently complicates SLE, is associated with significant morbidity and mortality, and its pathophysiology is poorly unde …
The role of mTOR signaling pathway in systemic lupus erythematosus and systemic vasculitis.
Michailidou D, Gartshteyn Y, Askanase AD, Perl A. Michailidou D, et al. Autoimmun Rev. 2025 Nov 28;24(11):103910. doi: 10.1016/j.autrev.2025.103910. Epub 2025 Aug 12. Autoimmun Rev. 2025. PMID: 40812528 Review.
In this review, we summarize how mTOR pathway may contribute to the pathogenesis of systemic lupus erythematosus (SLE) and systemic vasculitis. In SLE, mTOR activation induces activation of CD4 + T cells, skews differentiation towards Th17 cells …
In this review, we summarize how mTOR pathway may contribute to the pathogenesis of systemic lupus erythematosus (SLE) …
Diagnosis and management of autoimmune diseases in the ICU.
Dumas G, Arabi YM, Bartz R, Ranzani O, Scheibe F, Darmon M, Helms J. Dumas G, et al. Intensive Care Med. 2024 Jan;50(1):17-35. doi: 10.1007/s00134-023-07266-7. Epub 2023 Dec 19. Intensive Care Med. 2024. PMID: 38112769 Review.
A distinction should be made between connective tissue diseases (mainly systemic lupus erythematosus, systemic scleroderma, inflammatory muscle diseases, and rheumatoid arthritis) and vasculitides (mainly small-vessel vasculitis such as a …
A distinction should be made between connective tissue diseases (mainly systemic lupus erythematosus, systemic s …
8,411 results